Retaglutide is a innovative GLP-1 receptor agonist currently under study for the management of obesity. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://finnianemid902305.blogsumer.com/37986118/retaglutide-a-promising-glp-1-receptor-agonist